Home › Research › Brain tissue and pathology
Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS
Ilaria Linda Dellarole, Vittoria Aprea, Marcella Catania, Claudia Battipaglia, Aurora Romeo, Cristina Villa, Anna Burato, Luigi Celauro et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
TDP-43 seeding activity was detected in 67% of TDP-43-linked symptomatic patients, with a specificity of 93%. Almost half of presymptomatic subjects tested positive, mostly GRN carriers. Interestingly, among TDP-43_SAA positive presymptomatic individuals, two GRN carriers underwent phenoconversion. TDP-43_SAA can also detect misfolded TDP-43 in the CSF of presymptomatic individuals. A possible link exists between positive TDP-43_SAA and conversion to the symptomatic phase. HIGHLIGHTS: Seed amplification assay of transactive response (TAR) DNA-binding protein 43 (TDP-43_SAA) can detect misfolded TDP-43 in the cerebrospinal fluid (CSF) of patients with genetic frontotemporal dementia (FTD), linked to GRN and C9orf72 mutations. TDP-43_SAA can detect misfolded TDP-43 also in the CSF of presymptomatic individuals. In both groups, most TDP-43_SAA positive cases were carriers of GRN mutation. Two GRN carriers that resulted TDP-43_SAA positive converted to the symptomatic phase of the disease.
What this study adds
Evidence grade: Low
A seed amplification assay detected misfolded TDP-43 in the cerebrospinal fluid of 67% of symptomatic patients with genetic FTD/ALS and in almost half of presymptomatic carriers, mostly with GRN mutations. Two presymptomatic GRN carriers who tested positive later developed symptoms, suggesting a possible link between a positive test and conversion to the symptomatic phase.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Dellarole, I. L., Aprea, V., Catania, M., Battipaglia, C., Romeo, A., Villa, C., et al. (2025). Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS. Alzheimer s & Dementia. https://doi.org/10.1002/alz.70989
Vancouver
Dellarole IL, Aprea V, Catania M, Battipaglia C, Romeo A, Villa C, et al. Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS. Alzheimer s & Dementia. 2025. doi:10.1002/alz.70989. PMID: 41399249.
BibTeX
@article{dellarole2025-41399249,
author = {Dellarole, Ilaria Linda and Aprea, Vittoria and Catania, Marcella and Battipaglia, Claudia and Romeo, Aurora and Villa, Cristina and Burato, Anna and Celauro, Luigi and others},
title = {{Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.70989},
pmid = {41399249},
url = {https://doi.org/10.1002/alz.70989}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- TDP-43 seeding activity was detected in 67% of TDP-43-linked symptomatic patients, with a specificity of 93%.
- Almost half of presymptomatic subjects tested positive, mostly GRN carriers.
- Interestingly, among TDP-43_SAA positive presymptomatic individuals, two GRN carriers underwent phenoconversion.
- TDP-43_SAA can also detect misfolded TDP-43 in the CSF of presymptomatic individuals.
- A possible link exists between positive TDP-43_SAA and conversion to the symptomatic phase.
Why it matters
A seed amplification assay detected misfolded TDP-43 in the cerebrospinal fluid of 67% of symptomatic patients with genetic FTD/ALS and in almost half of presymptomatic carriers, mostly with GRN mutations. Two presymptomatic GRN carriers who tested positive later developed symptoms, suggesting a possible link between a positive test and conversion to the symptomatic phase.
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Paola Caroppo: h-index 36 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41399249) |
| Free to read | 2 / 2 | Free to read |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Brain tissue and pathology from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.